Status:
RECRUITING
Compliant Analysis of Patient Samples and Data
Lead Sponsor:
Sequenom, Inc.
Collaborating Sponsors:
Laboratory Corporation of America
Conditions:
Pregnancy Related
Cancer
Eligibility:
All Genders
Brief Summary
Patients of scientific interest who have provided a commercial sample to LabCorp or one of its' affiliates will have their de-identified remnant samples and/or data used for research and development. ...
Detailed Description
Arm 1 - Remnant commercial samples and data that has been de-identified of personal health information in compliance with HIPAA may be used for R\&D studies or population-based analysis by LabCorp or ...
Eligibility Criteria
Inclusion
- Arm 1
- All samples and data are de-identified and HIPAA compliant
- Arm 2
- Subject is of scientific interest to the Sponsor or treating physician
- Subject provides written informed consent and has a clinical sample and/or supporting clinical data collected.
Exclusion
- Arm 1
- Subject is from a US state or a country where local law restricts the use of de-identified data and/or remnants of specimens for research and/or development
- Arm 2
- Any medical or mental condition that would interfere with the subjects' ability to willingly give written informed consent
Key Trial Info
Start Date :
March 17 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 15 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04364503
Start Date
March 17 2018
End Date
August 15 2030
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sequenom, Inc
San Diego, California, United States, 92121